The conclusions of the 2016 G-FINDER report, to be launched at the event, provide policymakers, funders, researchers and industry with an understanding of how neglected disease research and development is funded around the world. Conducted by Policy Cures Research and funded by the Bill and Melinda Gates Foundation, the G-FINDER project has tracked and reported on investment into neglected disease R&D since 2008. It provides a unique window into the shifting global funding landscape for innovation in global health, helping to determining the next steps for R&D in Europe and the world.
- What does the latest information on the unprecedented global response to the Ebola epidemic tell us about how innovation for global health can be supported?
- How can Europe and the rest of the global health community make decisions about the role they will play in supporting innovation to address the health Sustainable Development Goals?
- How can the future EU research framework programme be relevant, credible and stimulate innovation in the field of global health?
- How can durable sustainable private, public and philanthropic funding for global health research and innovation be encouraged from Europe and the world?